The Subcutaneous Administration of Beta-Lactams: A Case Report and Literary Review-To Do Small Things in a Great Way.

IF 3.4 Q2 INFECTIOUS DISEASES
Gabriele Maria Leanza, Beatrice Liguoro, Simone Giuliano, Chiara Moreal, Luca Montanari, Jacopo Angelini, Tommaso Cai, Rita Murri, Carlo Tascini
{"title":"The Subcutaneous Administration of Beta-Lactams: A Case Report and Literary Review-To Do Small Things in a Great Way.","authors":"Gabriele Maria Leanza, Beatrice Liguoro, Simone Giuliano, Chiara Moreal, Luca Montanari, Jacopo Angelini, Tommaso Cai, Rita Murri, Carlo Tascini","doi":"10.3390/idr16010007","DOIUrl":null,"url":null,"abstract":"<p><p>The subcutaneous (s.c.) route is a commonly used method for delivering various drugs, although its application in the administration of antibiotics is relatively uncommon. In this case, we report a successful treatment of nosocomial pneumonia using piperacillin/tazobactam via continuous subcutaneous administration. Furthermore, this article provides an overview of the current literature regarding the s.c. administration of beta-lactam antibiotics. Based on our analysis, we identified only 15 studies that described the s.c. use of beta-lactam antibiotics in human subjects. Among these studies, cephalosporins were the most extensively investigated antibiotic class, with 10 available studies. According to the study findings, all three antibiotic classes (cephalosporins, penicillins, and carbapenems) demonstrated a similar pharmacokinetic profile when administered via the subcutaneous route. The subcutaneous route appears to be associated with a lower peak serum concentration (C<sub>max</sub>) but a comparable minimum blood concentration (C<sub>min</sub>) and an extended half-life (t<sub>1/2</sub>) when compared to conventional routes of antibiotic administration. Further research is necessary to determine whether subcutaneously administered beta-lactam antibiotics in human subjects achieve pharmacodynamic targets and demonstrate clinical efficacy.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 1","pages":"93-104"},"PeriodicalIF":3.4000,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10887887/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Disease Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/idr16010007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

The subcutaneous (s.c.) route is a commonly used method for delivering various drugs, although its application in the administration of antibiotics is relatively uncommon. In this case, we report a successful treatment of nosocomial pneumonia using piperacillin/tazobactam via continuous subcutaneous administration. Furthermore, this article provides an overview of the current literature regarding the s.c. administration of beta-lactam antibiotics. Based on our analysis, we identified only 15 studies that described the s.c. use of beta-lactam antibiotics in human subjects. Among these studies, cephalosporins were the most extensively investigated antibiotic class, with 10 available studies. According to the study findings, all three antibiotic classes (cephalosporins, penicillins, and carbapenems) demonstrated a similar pharmacokinetic profile when administered via the subcutaneous route. The subcutaneous route appears to be associated with a lower peak serum concentration (Cmax) but a comparable minimum blood concentration (Cmin) and an extended half-life (t1/2) when compared to conventional routes of antibiotic administration. Further research is necessary to determine whether subcutaneously administered beta-lactam antibiotics in human subjects achieve pharmacodynamic targets and demonstrate clinical efficacy.

β-内酰胺类药物的皮下注射:病例报告和文学评论--以小见大。
皮下注射(s.c.)是一种常用的给药方法,但在抗生素给药中的应用却相对较少。在本病例中,我们报告了通过持续皮下给药使用哌拉西林/他唑巴坦成功治疗非典型肺炎的案例。此外,本文还概述了目前有关经皮下注射β-内酰胺类抗生素的文献。根据我们的分析,我们仅发现 15 项研究描述了在人体中皮下注射β-内酰胺类抗生素的情况。在这些研究中,头孢菌素是调查最广泛的抗生素类别,共有 10 项研究。研究结果表明,所有三类抗生素(头孢菌素类、青霉素类和碳青霉烯类)在通过皮下途径给药时都表现出相似的药代动力学特征。与常规抗生素给药途径相比,皮下途径的血清浓度峰值(Cmax)较低,但最低血药浓度(Cmin)和半衰期(t1/2)却相当。要确定人体皮下注射的β-内酰胺类抗生素是否能达到药效学目标并显示临床疗效,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infectious Disease Reports
Infectious Disease Reports INFECTIOUS DISEASES-
CiteScore
5.10
自引率
0.00%
发文量
82
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信